KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Receivables (2016 - 2018)

Historic Change in Receivables for Evolent Health (EVH) over the last 4 years, with Q3 2018 value amounting to -$9.9 million.

  • Evolent Health's Change in Receivables fell 24849.66% to -$9.9 million in Q3 2018 from the same period last year, while for Sep 2018 it was $17.4 million, marking a year-over-year increase of 2004.96%. This contributed to the annual value of $11.3 million for FY2017, which is 193.77% up from last year.
  • As of Q3 2018, Evolent Health's Change in Receivables stood at -$9.9 million, which was down 24849.66% from $4.2 million recorded in Q2 2018.
  • In the past 5 years, Evolent Health's Change in Receivables registered a high of $16.9 million during Q1 2018, and its lowest value of -$10.2 million during Q2 2015.
  • Its 4-year average for Change in Receivables is $1.6 million, with a median of $4.1 million in 2017.
  • The largest annual percentage gain for Evolent Health's Change in Receivables in the last 5 years was 32310.77% (2018), contrasted with its biggest fall of 24849.66% (2018).
  • Evolent Health's Change in Receivables (Quarter) stood at -$8.1 million in 2015, then skyrocketed by 216.63% to $9.4 million in 2016, then plummeted by 34.5% to $6.2 million in 2017, then crashed by 259.34% to -$9.9 million in 2018.
  • Its Change in Receivables stands at -$9.9 million for Q3 2018, versus $4.2 million for Q2 2018 and $16.9 million for Q1 2018.